DAY 1 Monday, 22 June 2020 |
11:00 - 13:00 |
Registration and welcome coffee |
13:00 - 14:00 |
|
Keynote lecture: John de Groot, MD Anderson Cancer Center, USA Tbc
|
14:00 - 17:20 |
Brain tumor pathobiology (chairs: Dolores Hambardzumyan, Bozena Kaminska) |
14:00 - 14:35 |
|
Constantinos G. Hadjipanayis, Mount Sinai Hospital, USA Fluorescence-guided surgery and photodynamic therapy of brain tumors: a new combination |
14:35 - 15:10 |
|
Kenneth Aldape, National Cancer Institute, USA Tbc |
15:10 - 15:40 |
COFFEE BREAK |
15:40 - 16:15 |
|
Oren Becher, Northwestern University, USA Cellular heterogeneity in diffuse midline gliomas |
16:15 - 16:50 |
|
Jacek Majewski, McGill University, Canada Epigenomic landscapes of H3K27M mutant gliomas |
16:50 - 17:20 |
|
Oral presentations(3x10 min) |
17:20 - 18:50 |
Poster session part I |
19:00 - 21:00 |
WELCOME RECEPTION |
|
|
|
DAY 2 Tuesday, 23 June 2020 |
09:00 - 12:25 |
Glioma microenvironment, immunology and immunotherapy I (chairs: Christel Herold-Mende, Aleksandra Ellert-Miklaszewska) |
09:00 - 09:35 |
|
Bozena Kaminska, Nencki Institute, Warsaw, Poland Immune microenvironment of glioma at single cell resolution |
09:35 - 10:10 |
|
Dolores Hambardzumyan, Emory University, School of Medicine, Atlanta, USA Glioblastoma subtype-specific heterogeneity of the immune microenvironment |
10:10 - 10:40 |
COFFEE BREAK |
10:40 - 11:15 |
|
Katrin Lamszus,Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Cancer immunoediting in malignant glioma - interactions between immune cells and tumor cells |
11:15 - 11:50 |
|
Neta Erez, Tel Aviv University, Israel Astrocyte-mediated neuroinflammation facilitates melanoma brain metastasis |
11:50 - 12:25 |
|
Christel Herold-Mende, University of Heidelberg, Germany Molecular determinants of immune cell infiltration in brain tumors |
12:25 - 13:25 |
LUNCH BREAK
|
13:25 - 18:00 |
Glioma microenvironment, immunology and immunotherapy II (chairs: Dinorah Friedman-Morvinski, Wiesława Grajkowska) |
13:25 - 14:00 |
|
Martin van den Bent, Erasmus MC Cancer Institute Rotterdam Netherlands Tbc |
14:00 - 14:35 |
|
Anna Kenney, Winship Cancer Institute, Emory University, USA Radiation resistance in the medulloblastoma perivascular niche |
14:35 - 15:10 |
|
Dieter Henrik Heiland, University of Freiburg, Germany The role of glial microenvironment in the dysregulation of immune surveillance of brain tumors |
15:10 - 15:35 |
COFFEE BREAK |
15:35 - 16:10 |
|
Dinorah Friedmann-Morvinski, Tel Aviv University, Israel Adoptive T-cell immunotherapy with potential dual function for the treatment of glioblastoma |
16:10 - 16:45 |
|
Waldemar Debinski, Wake Forest School of Medicine, USA Markers of Macrophage Activation in Glioblastoma |
16:45 - 17:20 |
|
Alessandro Michelucci, Neuro-Immunology Group, Department of Oncology, Luxembourg Institute of Health, Luxembourg Revealing and harnessing tumour-associated microglia/macrophage heterogeneity in glioblastoma |
17:20 - 17:40 |
|
Advanced in single cell omics (10X Genomics) |
17:40 - 18:10 |
|
Oral presentations (3x10 min) |
18:10 - 19:30 |
Poster session part II |
20:00 - 23:00 |
Gala dinner (by invitation) |
|
|
|
DAY 3 Wednesday, 24 June 2020 |
09:00 - 16:00 |
Brain tumor pathobiology, diagnostics & therapy (chairs: Tika Benveniste, Sergiusz Nawrocki) |
09:00 - 09:35 |
|
Itay Tirosh, Weizmann Institute of Science, Israel Dissecting intra-tumor and inter-tumor heterogeneity in glioma
|
09:35 - 10:10 |
|
Agnieszka Bronisz, Harvard Medical School/Mossakowski Medical Institute, Poland
Targeting hypoxia response for oncolytic virus immunotherapy
|
10:10 - 10:40 |
COFFEE BREAK |
10:40 - 11:15 |
|
Guido Reifenberger, University of Dusseldorf, Germany Tbc |
11:15 - 11:50 |
|
Hai-kun Liu, University of Heidelberg, Germany
Metabolic reprograming in dormant brain tumor stem cells
|
11:50 - 12:25 |
|
Maria G. Castro, University of Michigan, USA Epigenetic reprogramming of the tumor immune microenvironment in mutant IDH1 gliomas mediated myeloid cell populations and reverses immunosuppression |
12:25 - 13:25 |
LUNCH |
13:25 - 14:00 |
|
Maciej Wiznerowicz, International Institute for Molecular Oncology, Poland Cancer Stemness as Hallmark of Oncogenic De-differentiation |
14:00 - 14:35 |
|
Houtan Noushmehr, Henry Ford Cancer Institute, USA Advances in Epigenomic Classification and Liquid Biopsy in Glioma |
14:35 - 15:10 |
|
Petra Hamerlik, Danish Cancer Society Research Center, Denmark Functional interplay between aberrant DNA repair and cellular hierarchies in glioblastoma |
15:10 - 15:45 |
|
Waldemar Priebe, MD Anderson Cancer Center, University of Texas, Houston, USA Drug Discovery in Academia: Focus on CNS Malignancies |
15:45 - 16:00 |
Closing remarks |
16:00 - 19:00
|
Guided tour: Warsaw sightseeing (optional, free of charge) |
 |